[Federal Register Volume 85, Number 250 (Wednesday, December 30, 2020)]
[Notices]
[Pages 86556-86557]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-28828]
=======================================================================
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPP-2020-0514; FRL-10018-29]
Atrazine, Simazine, and Propazine Registration Review; Draft
Endangered Species Act Biological Evaluations; Extension of Comment
Period
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice; extension of comment period.
-----------------------------------------------------------------------
SUMMARY: EPA issued a notice in the Federal Register of November 6,
2020, opening a 60-day comment period on the draft nationwide
biological evaluations for the registration review of the pesticides
atrazine, simazine, and propazine relative to the potential effects on
threatened and endangered species and their designated critical
habitats. This document extends the comment period for 45 days, from
January 5, 2021 to February 19, 2021.
DATES: Comments, identified by docket identification (ID) number EPA-
HQ-OPP-2020-0514 must be received on or before February 19, 2021.
ADDRESSES: Follow the detailed instructions provided under ADDRESSES in
the Federal Register document of November 6, 2020 (85 FR 71071) (FRL-
10015-77).
FOR FURTHER INFORMATION CONTACT: Tracy Perry, Pesticide Re-Evaluation
Division (7508P), Office of Pesticide Programs, Environmental
Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460-
0001; telephone number: (703) 308-0128; email address:
[email protected].
SUPPLEMENTARY INFORMATION: This document extends the public comment
period established in the Federal Register document of November 6, 2020
(85 FR 71071) (FRL-10015-77), which opened a 60-day public comment
period for the draft nationwide biological evaluations for the
registration review of the pesticides atrazine, simazine, and propazine
relative to the potential effects on threatened and endangered species
and their designated critical habitats. As noted in that document, the
schedule for conducting the atrazine and simazine biological
evaluations was negotiated as part of a partial settlement agreement
pursuant to a joint
[[Page 86557]]
stipulation filed on October 18, 2019 and entered by the court on
October 22, 2019, in Center for Biological Diversity et al. v. EPA et
al. (N.D. Ca) (3:11-cv-00293). EPA stated in this settlement that it
would also include propazine in this group of effects determinations.
EPA is hereby extending the public comment period, which was set to end
on January 5, 2021, to February 19, 2021.
After considering a number of requests to extend the comment period
received from various stakeholders, EPA is extending the comment period
for the following reasons: (1) The length, complexity, and highly
technical nature of the draft biological evaluations; (2) the need for
some stakeholders to engage experts familiar with the subject matter to
assist them with providing comments; (3) the large number of
stakeholders potentially impacted by the draft biological evaluations;
(4) the importance of soliciting feedback from stakeholders who may be
affected; and (5) the stakeholders' need for additional time to review
and develop constructive comments for these complex and lengthy
documents.
To submit comments, or access the docket, please follow the
detailed instructions provided under ADDRESSES in the Federal Register
document of November 6, 2020. If you have any questions regarding the
applicability of this action to a particular entity, consult the person
listed under FOR FURTHER INFORMATION CONTACT.
Authority: 7 U.S.C. 136 et seq.
Dated: December 8, 2020.
Alexandra Dapolito Dunn,
Assistant Administrator, Office of Chemical Safety and Pollution
Prevention.
[FR Doc. 2020-28828 Filed 12-29-20; 8:45 am]
BILLING CODE 6560-50-P